Navigation Links
Abattis Biologix Corporation Begins Trading on Pink Sheets
Date:6/17/2011

VANCOUVER, British Columbia, June 17, 2011 /PRNewswire/ -- Abattis Biologix Corporation (CNSX: FLU) announced today that their shares have commenced trading on the OTC Pink Sheets under the symbol ABBTF. Pink Sheet trading will provide shareholders with liquidity as the company proceeds with financing activities and the preparation of additional disclosure documents for listing on higher tier OTC platforms and other exchanges.

Mike Withrow, CEO of Abattis stated, "This is the first in three steps toward becoming a fully reporting issuer with the SEC. The company is fully reporting in Canada and is in the process of converting to IFRS. It will provide transparency about our company in both countries and better access to its stock in the US, which will attract new investors and expand our stockholder base."

"We continue to strengthen our IP and are preparing to launch our portfolio of proprietary products into strategic distribution channels. Shareholders and investors should expect to see additional news releases in the coming weeks on these and other events and activities as we move toward that goal," added Withrow.

About Abattis Biologix Corp.

Abattis Biologix Corporation is committed to the research, development and marketing of proprietary natural health and wellness solutions that address chronic illnesses through targeted nutritional support.  We manufacture and market the most scientifically advanced natural therapeutic formulas based on proprietary technologies through multiple distribution channels, while providing the highest level of customer service.

Web: www.abattis.com     Twitter:@abattis

Safe Harbor Statement: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated.

Media Contact:
Margie Adelman
madelman@adelmanpr.com
916 220 3500

Investor Relations Contact:
Gil Schneider
Gil.schneider@abattis.com
604 828 8600


'/>"/>
SOURCE Abattis Biologix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
2. Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada
3. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
4. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
5. AmbiCom Forms Joint Alliance With E-Care Technology Corporation
6. Volcano Corporation Presentation at William Blair Conference to be Webcast
7. President of Minntech Corporation Injured in Plane Crash
8. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
10. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
11. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
Breaking Medicine Technology:
(Date:5/2/2016)... , ... May 02, 2016 , ... Dr. Philip Shindler, ... patients with same day treatments. In the past, many necessary dental treatments could require ... along with multiple anesthetic shots and extra chair time. Not only could this be ...
(Date:5/2/2016)... Naperville, Illinois (PRWEB) , ... May 02, 2016 , ... ... our modernized mail back service. MedPro now offers its mail back service for ... this offer; we are now able to provide service to all of the clients ...
(Date:5/2/2016)... NV (PRWEB) , ... May 02, 2016 , ... ... Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award that will ... based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction ...
(Date:5/2/2016)... ... , ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed roster was announced in February ... The WUGC is being held in London, England this year from June 18-25. At the ... another gold in the women’s masters division, and a silver in the women’s division, so ...
(Date:5/2/2016)... ... 02, 2016 , ... Pregnancy Awareness Month offers a great time to get ... “If you are ready to have a baby, it’s best to get started before ... is your Personal Conception & Pregnancy Organizer, written for women who plan on becoming ...
Breaking Medicine News(10 mins):